These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16228621)

  • 1. Pharmaceutical policy and the lay public.
    Traulsen JM; Almarsdóttir AB
    Pharm World Sci; 2005 Aug; 27(4):273-7. PubMed ID: 16228621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways to translating experiential knowledge into mental health policy.
    Restall G; Cooper JE; Kaufert JM
    Psychiatr Rehabil J; 2011; 35(1):29-36. PubMed ID: 21768075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of users in innovation in the pharmaceutical industry.
    Smits RE; Boon WP
    Drug Discov Today; 2008 Apr; 13(7-8):353-9. PubMed ID: 18405849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Public participation and civic participation of service users in relation to the Mental Health Action Plan 2005-2010: their spokesperson function].
    Pelletier JF; D'Auteuil S; Ducasse C; Rodriguez Del Barrio L
    Sante Ment Que; 2014; 39(1):175-93. PubMed ID: 25120121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying and evaluating pharmaceutical policy--becoming a part of the policy and consultative process.
    Almarsdóttir AB; Traulsen JM
    Pharm World Sci; 2006 Feb; 28(1):6-12. PubMed ID: 16810452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do pharmaceutical industry professionals in Europe believe about involving patients and the public in research and development of medicines? A qualitative interview study.
    Parsons S; Starling B; Mullan-Jensen C; Tham SG; Warner K; Wever K
    BMJ Open; 2016 Jan; 6(1):e008928. PubMed ID: 26743701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engaging citizens in local health policymaking. A realist explorative case-study.
    De Weger E; Drewes HW; Van Vooren NJE; Luijkx KG; Baan CA
    PLoS One; 2022; 17(3):e0265404. PubMed ID: 35324975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The argument for pharmaceutical policy.
    Traulsen JM; Almarsdóttir AB
    Pharm World Sci; 2005 Feb; 27(1):7-12. PubMed ID: 15861928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
    Mubyazi GM; Gonzalez-Block MA
    Malar J; 2005 Oct; 4():51. PubMed ID: 16242017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the use of health systems and policy research in the health policymaking process in Israel: views of researchers.
    Ellen ME; Lavis JN; Shemer J
    Health Res Policy Syst; 2016 Sep; 14(1):66. PubMed ID: 27585630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Wrong parents' and 'right parents': shared perspectives about citizen participation in policy implementation.
    Potter DA
    Soc Sci Med; 2010 Jun; 70(11):1705-13. PubMed ID: 20227806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical policy and the pharmacy profession.
    Traulsen JM; Almarsdóttir AB
    Pharm World Sci; 2005 Oct; 27(5):359-63. PubMed ID: 16341741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A look at a successful fee-charging urban project.
    Traitongyoo T
    JOICFP Rev; 1985 Oct; 10():32-4. PubMed ID: 12313885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. User participation in community mental health services: exploring the experiences of users and professionals.
    Elstad TA; Eide AH
    Scand J Caring Sci; 2009 Dec; 23(4):674-81. PubMed ID: 19804372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whose voices? Patient and public involvement in clinical commissioning.
    O'Shea A; Chambers M; Boaz A
    Health Expect; 2017 Jun; 20(3):484-494. PubMed ID: 27358109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social goals, health policy and the dynamics of development as bases for health education.
    Wang VL
    Int J Health Educ; 1977; 20(1):13-8. PubMed ID: 857480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different public health geographies of the 2001 foot and mouth disease epidemic: 'citizen' versus 'professional' epidemiology.
    Bailey C; Convery I; Mort M; Baxter J
    Health Place; 2006 Jun; 12(2):157-66. PubMed ID: 16338631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.